188 results about "Pharmaceutical manufacturing" patented technology

A system and method for using near-infrared or short-wave infrared (SWIR) light sources for identification of counterfeit drugs may perform spectroscopy using a super-continuum laser to provide detection in a non-contact and non-destructive manner at stand-off or remote distances with minimal sample preparation. Also, near-infrared or SWIR light may penetrate through plastic containers and packaging, permitting on-line inspection and rapid scanning. The near-infrared or SWIR spectroscopy may also be used to detect illicit drugs and their chemical composition. Moreover, the spectroscopic techniques may also be applied to quality assessment and control in pharmaceutical manufacturing, thus permitting the implementation of smart manufacturing with feedback control. Fiber super-continuum lasers may emit light in the near-infrared or SWIR between approximately 1.4-1.8 microns, 2-2.5 microns, 1.4-2.4 microns, 1-1.8 microns. In particular embodiments, the detection system may be a dispersive spectrometer, a Fourier transform infrared spectrometer, or a hyper-spectral imaging detector or camera.

Embodiments of the present invention are directed to a customizable bio-manufacturing system which includes a manufacturing space having a first air handling system for providing supply air and a second air handling system for handling exhaust air, the supply air system being optionally provided with at least one of filtration, heating, cooling and or humidity control and a plurality of portable modules provided within the manufacturing space. At least one module having an interior capable of being interconnected with another module interior and each module's interior includes one or more components to perform at least one specific task of a biological, chemical, and/or pharmaceutical manufacturing process. At least one module includes an on-board environmental control system for controlling an environment within the module and a connection means for interconnecting the module interior with another module interior. The system also includes a central controller operating to at least perform one or more of operation and information collection for the operation of at least one of the system and one or more modules.

Methods, systems, and software program for validation of pharmaceutical manufacturing processes and quality assurance process are described and disclosed herein. Consequently, the methods provide a means to perform validation on an integrated level whereby the quality control unit can ensure data and product integrity and minimize cost.

Disclosed herein is a single use, controlled environment manufacturing module in the form of a sterile sealed bag formed of a substantially flexible material, such that the bag can be inflated and deflated for transport and/or disposal. The flexible bag has one or more access ports and connectors to accommodate a variety of biochemical or pharmaceutical manufacturing processes to be carried out within the flexible bag. The interiors of one or more disclosed modules can be connected, forming a module train.

Have invented a new strut system designed for the attachment of pipes, conduit, and tubes to vertical and horizontal surfaces in a sanitary manner. The mounting of pipes, conduits or tubes in an environment that demands a high level of sanitation, (i.e.; food processing and pharmaceutical manufacturing) is best accomplished through the use of my invention. Unlike strut systems currently available, my strut system repels contaminants, is easy to inspect, and easy to clean.

The invention relates to the field of medicine manufacturing techniques, in particular to a metronidazole API preparation method, and solves the problems that a current metronidazole preparation method is high in cost and low in yield. The method comprises the following steps: (1), acid mixing, adding 100 parts (by weight) of formic acid of concentration of 95-99 percent in a reaction kettle for stirring to a temperature of 20 DEG C, then adding 25-35 parts (by weight) of concentrated sulphuric acid, so as to prepare the mixed acid for further use; (2), synthesis reaction, adding 100-120 parts (by weight) of reaction raw materials 2-methyl-5-nitroimidazole into a reaction tank, and adding the mixed acid prepared in the step 1, stirring to a temperature of 75-80 DEG C, completely dissolving the 2-methyl-5-nitroimidazole, and maintaining 10-20 minutes. According to the invention, the design is reasonable; and the mixed acid is adopted to provide an acidic condition, an applicable reaction raw material ratio and an appropriate control reaction parameter, so as to allow the yield of the nitroimidazole to reach 65-70 percent.

The invention provides a preparation method for a diamine cross-linked modified polyimide nano-filtration membrane added with polyethylene glycol and aims to solve the problems that the permeation flux of the prepared polyimide nano-filtration membrane is low, the rejection rate is low and the preparation cost is high in an existing method. The preparation method provided by the invention comprises the following steps: 1, preparing polyimide membrane casting liquid with the mass percent of 15%-25%; 2, preparing polyethylene glycol-polyimide membrane casting liquid, wherein the mass percent of the polyethylene glycol in the polyethylene glycol-polyimide membrane casting liquid is 1-20wt%; 3, carrying out membrane preparation by using an immersing precipitated phase conversion method to obtain the polyimide nano-filtration membrane; 4, processing the obtained polyimide nano-filtration membrane by using diamine to obtain a modified polyimide nano-filtration membrane; and 5, immersing and washing 2-4 times to obtain the diamine cross-linked modified polyimide nano-filtration membrane added with the polyethylene glycol. The preparation method for the diamine cross-linked modified polyimide nano-filtration membrane added with the polyethylene glycol is applied to fields including pharmaceutical manufacturing, biology, catalyst recycling and the like.

A system and method for detecting, measuring, and analyzing for metallic impurities in pharmaceutical drugs and compounds utilizes an x-ray fluorescence system. The system and method may be co-located with a pharmaceutical manufacturing process for in-line continuous monitoring of metal impurities. The pharmaceutical products may be in a form selected from a powder, slurry, pill, tablet, and gel.

The invention provides a preparation method for a monoamine-grafted-and-modified crosslinked polyimide solvent-resistant nanofiltration membrane. The preparation method comprises the following steps: a, preparing a mixed solution from a solvent and a cosolvent according to a mass ratio of 1: 0.1-5; b, adding 15 to 28% of a polyimide solution into the mixed solution so as to prepare a membrane casting liquid; c, adding 2.5 to 20% of monoamine into the membrane casting liquid and carrying out mixing at 25 to 80 DEG C for 3 to 24 h under stirring so as to guarantee complete grafting; d, preparing a membrane by using a immersion-precipitation phases inversion process, washing the prepared membrane with deionized water a plurality of times and standing the washed membrane for subsequent usage; e, preparing an alcoholic solution of diamine with a concentration of 0.5 to 20%; f, putting the prepared membrane in the alcoholic solution of diamine prepared in the previous step for crosslinking modification for 0.25 to 48 h; and g, after completion of the reaction, soaking and cleaning the membrane in an alcohol solvent so as to obtain the polyamide nanofiltration membrane with excellent performance. The polyimide solvent-resistant nanofiltration membrane prepared in the invention has the advantages of simple preparation, adjustable hydrophilicity, outstanding solvent resistance, great permeation flux, a high retention rate, etc. and is applicable to separation of substances in all the organic solvents and to the fields of pharmaceutical manufacturing, biology, catalyst recovery, etc.

The invention relates to a horizontal shell and tube type condenser with liquid guide devices. At present, when designing the horizontal shell and tube type condenser, people compensate the negative influence of tube bundle effect on the condensation heat exchange only by increasing the amount of heat exchange tubes so as to cause increase of the volume of heat-exchange equipment and the improvement of the production cost. The horizontal shell and tube type condenser with the liquid guide devices comprises a shell (1). Both sides of the shell are connected with a tube plate (2). A space inside the shell surrounded by the shell and the tube plate is provided with a set of heat exchange tubes (3). The heat exchange tubes are provided with support plates (4). Continuous liquid guide devices (5) are installed below the heat exchange tube and are collection liquid guide device or separation liquid guide devices. The shell is provided with an air inlet (9) and a liquid outlet (10). The invention can be widely applied in the fields of petroleum, chemical industry, metallurgy, pharmaceutical manufacturing, air conditioning, refrigeration, heat supply and the like.

A web-based tool (as a server) for integrated pharmaceutical analysis and report generation service is provided in the present invention. The server can be used for numerical analysis and report generation for pharmaceutical manufacturing, research and development, and has advantages such as simple operation, complicated but fast calculation and professional report generation, and high accuracy. The server includes at least one pharmaceutical manufacturing and research and development numerical analysis system configured to perform different pharmaceutical manufacturing and research and development numerical analyses and generate different reports. Each of the at least one pharmaceutical manufacturing and research and development numerical analysis system includes an input module configured to receive, via a user interface, at least one of a template file and a backup file previously output by the server as at least one input file, wherein the at least one input file includes a plurality of data fields to provide corresponding data; at least one calculation module, each configured to execute a built-in pharmaceutical manufacturing and research and development numerical analysis calculation program, thereby automatically performing a pharmaceutical manufacturing and research and development numerical analysis calculation on at least one of the data of the at least one input file and on-line filled data; and an output module configured to generate at least one of a backup file and a report file as at least one output file based on the result of the pharmaceutical manufacturing and research and development numerical analysis calculation performed by the at least one calculation module and provide the at least one file via the user interface.

The invention belongs to the technical field of biological pharmaceutical manufacturing, and particularly relates to a transfer faction solution and a preparation method thereof. The preparation method comprises the following steps: mixing animal spleen and NaCl solution according to a weight ratio of 1:(1.3-1.4), performing repeated freeze-thaw, adjusting the pH value to 6.2-7.2, and filtering to obtain the transfer faction solution. By the adoption of the method provided by the invention, the content of effective components in the transfer faction solution can be increased advantageously, the product yield is improved, and the stability and the safety of a medicine are improved.

The invention belongs to the technical field of medicinal preparations, and concretely relates to a medicinal composition of paclitaxel. The medicinal composition comprises, by weight, 2.87-27.66 parts of paclitaxel and 100 parts of mPEG-PLA-phenylalanine. The medicinal composition has the following advantages: 1, the in vitro stability is high, and a re-dissolved paclitaxel solution keeps stable at room temperature for above 12h to meet medicinal treatment requirements; 2, the medicinal composition has high stability in blood and small particle size, and can easily perform the ERP effect; 3, a novel micelle carrier is adopted, so the toxicity is low, and the safety is high; and 4, a pharmacy common freeze-drying technology is directly adopted to prepare freeze-dried powder, so the medicinal composition is simple to prepare, and is convenient to transport and store, and untoward effects brought by the addition of an excipient are avoided The medicinal composition can be instantly re-dissolved by using common normal saline or glucose injection, so the administration process is greatly simplified.

The present invention provides a method for preparing a sterile suspension of a glucocorticosteroid. The glucocorticosteroids used in the invention are preferably antiinflammatory glucocorticosteroids. By making the last stage of product preparation be the sterilization process, the potential for contamination during manufacture and heat degradation of products is greatly reduced.

The invention provides an abiraterone derivative with an anti-cancer effect. The general structural formula of the abiraterone derivative is as shown in the description. The abiraterone derivative can ensure improvement of biophysics properties such as abiraterone solubility and bioavailability; the stability of the abiraterone derivative is maintained very well during pharmaceutical manufacturing and drug administration; and after drug administration, the abiraterone derivative can be degraded and release active compounds; and the abiraterone derivative has the characteristics of low toxicity and the like.

The invention relates to the technical field of Chinese pharmaceutical manufacturing, particularly to a method for extracting and further processing ainsliaea fragrans total flavonoid. With ainsliaea fragrans adopted as the raw medicinal material, the method comprises the following steps: firstly, smashing ainsliaea fragrans; carrying out ultrasonic immersion extraction on the smashed ainsliaea fragrans in ethanol water for a plurality of times; then, combining extracting solutions; decompressing and concentrating the extracting solutions; adding ethyl alcohol into the concentrated solution, and carrying out low-temperature standing for alcohol precipitation; filtering with a micropore filter membrane; decompressing and concentrating the filtrate; carrying out vacuum drying on the concentrated solution to obtain refined ainsliaea fragrans total flavonoid extract; finally, adding pharmaceutical excipients for further preparing the ainsliaea fragrans total flavonoid extract into various pharmaceutical preparations. According to the method, ultrasonic wave and continuous countercurrent extraction technologies are combined, so that the dissolution and spreading of the effective components are quickened, the extraction time is greatly shortened, the extraction efficiency is improved, the degradation of heat sensitive components is avoided, the energy consumption and production cost are further reduced, the extraction preparation technology is relatively simple and convenient, and the method is applicable to industrial large-scale production.

The invention relates to a peach seed-safflower Siwu granule containing medicinal materials like peach seed, safflower, Chinese angelica, common peony root, prepared rehmannia root and Ligusticum wallichii, and a preparation method thereof, belonging to the technical field of Chinese pharmaceutical manufacturing. The preparation method comprises the following steps: crushing peach seed, safflower, Chinese angelica, common peony root, prepared rehmannia root and Ligusticum wallichii, then adding water for decoction, combining two obtained decoctions, and then successively carrying out filtering, pressure-reduced concentration and spray drying so as to obtain dry powder; and then adding sugar and dextrin and then successively carrying out uniform mixing, granulation, drying and size finishing so as to obtain the peach seed-safflower Siwu granule. According to the invention, a spray drying manner is employed; product quality can be improved; quality indexes like the particle size distribution, moisture content, biological activity and dissolvability of drugs are controlled; and product purity and production efficiency are enhanced.

The invention relates to the field of pharmaceutical manufacturing equipment, in particular to a drying system. A cold and hot air alternative drying system comprises a drying cylinder and a heat pump connected with the drying cylinder; an air inlet pipeline is arranged between an air outlet of the heat pump and the drying cylinder; the cold and hot air alternative drying system further comprises a cold air blower; and an air outlet of the cold air blower is communicated with the drying cylinder through the air inlet pipeline. A photocatalyst device is arranged in the air inlet pipeline. Due to the adoption of the technical scheme, herbs are dehydrated at first, and then are dried through alternation of cold air and hot air to fully ensure the drying property of herbs; and the arrangement of the photocatalyst device solves the problem of sterilization of the cold air and hot air in the drying process.

A kind of medicine for treating carbuncle, gangrene, swollen poison and skin ulcer. It is made from Aconitum aconitum, Aconitum aconitum, Forsythia, Rehmannia glutinosa, frankincense, myrrh, wood turtle seed, cinnamon, dried blood, mercury powder, yellow dan, and sesame oil When making this drug, the weighed medicinal material should be immersed in the weighed sesame oil, soaked for 2 hours to 5 days, then heated, fried until the drug is browned, and then the fried drug is filtered out, and Huangdan is added and dried. Stir continuously, after cooling, it is the finished product; since there are fewer drug components in the drug of the present invention, and the price of each component is cheaper, the cost of this drug is lower; these medicinal materials are produced through proper compatibility Good therapeutic effect is obtained; the medicine in the present invention also has the advantage of simpler manufacturing process.